切换至 "中华医学电子期刊资源库"

中华细胞与干细胞杂志(电子版) ›› 2020, Vol. 10 ›› Issue (01) : 32 -36. doi: 10.3877/cma.j.issn.2095-1221.2020.01.006

所属专题: 文献

论著

慢病毒介导的c-Myc启动子结合蛋白1过表达对结肠癌HCT116细胞增殖与凋亡的影响及其机制研究
李月华1, 曹爽1,()   
  1. 1. 442000 十堰,湖北省十堰市人民医院(湖北医药学院附属人民医院)肿瘤科
  • 收稿日期:2019-05-07 出版日期:2020-02-01
  • 通信作者: 曹爽

Role and mechanisms of lentivirus mediated MBP-1 overexpression in the regulation of proliferation and apoptosis of colon cancer HCT116 cells

Yuehua Li1, Shuang Cao1,()   

  1. 1. Department of Oncology, People's Hospital of Shiyan City, Hubei Medical College Affiliated People's Hospital, Shiyan 442000, China
  • Received:2019-05-07 Published:2020-02-01
  • Corresponding author: Shuang Cao
  • About author:
    Corresponding author: Cao Shuang, Email:
引用本文:

李月华, 曹爽. 慢病毒介导的c-Myc启动子结合蛋白1过表达对结肠癌HCT116细胞增殖与凋亡的影响及其机制研究[J]. 中华细胞与干细胞杂志(电子版), 2020, 10(01): 32-36.

Yuehua Li, Shuang Cao. Role and mechanisms of lentivirus mediated MBP-1 overexpression in the regulation of proliferation and apoptosis of colon cancer HCT116 cells[J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2020, 10(01): 32-36.

目的

探讨慢病毒介导的c-Myc启动子结合蛋白1 (MBP-1)过表达对结肠癌HCT116细胞增殖和凋亡的影响及其机制。

方法

将体外培养的HCT116细胞分为以下3组:空白对照组,细胞未做任何处理;空载感染组,空载体对照慢病毒(LV-GFP)感染HCT116细胞;MBP-1过表达慢病毒组(MBP-1组),MBP-1过表达的重组慢病毒(LV-MBP-1-GFP)感染HCT116细胞。RT-PCR检测各组细胞中MBP-1 mRNA的表达,CCK-8实验检测细胞的增殖能力,流式细胞仪检测细胞的周期变化,Western blot检测细胞中MBP-1、NF-κB p65、c-Myc、CyclinD1及细胞凋亡相关蛋白Bcl-2、Bax、cleaved caspase-3的表达。三组间比较采用单因素方差分析,方差齐性采用F检验,若方差齐则组间比较采用LSD检验,若方差不齐则组间比较采用Dunnett检验。

结果

与空载感染组比较,MBP-1组在MBP-1 mRNA (1.02±0.15比4.56±1.03)、蛋白表达水平(0.18±0.01比0.72±0.10)、S期百分比[(39.12±2.18)﹪比(45.64±3.21)﹪]、G2/M期的百分比[(14.81±1.02)﹪比(23.16±2.12)﹪]、细胞中Bax蛋白(0.55±0.10比0.76±0.11)、cleaved caspase-3蛋白(0.45±0.08比0.81±0.11)表达水平均升高,差异具有统计学意义(P均< 0.001),而细胞48 h OD值(0.58±0.08比0.43±0.03)、72 h OD值(1.10±0.13比0.52±0.09)、细胞G0/G1期的百分比[(46.06±1.89)﹪比(31.36±2.02)﹪]、细胞中Bcl-2蛋白(0.52±0.10比0.23±0.02)、NF-κB p65蛋白(0.61±0.13比0.16±0.03)、c-Myc蛋白(0.79±0.15比0.43±0.05)、CyclinD1蛋白(0.62±0.09比0.32±0.01)的表达水平均降低,差异具有统计学意义(P均< 0.001);空白对照组和空载感染组之间各指标差异无统计学意义(P > 0.05)。

结论

MBP-1过表达可抑制HCT116细胞增殖及诱导细胞周期阻滞于S期,其作用机制可能与抑制NF-κB信号通路活化有关。

Objective

To investigate the role and mechanisms of lentivirus-mediated overexpression of c-Myc promoter binding protein-1 (MBP-1) gene in the regulation of proliferation and apoptosis of colon cancer HCT116 cells and its mechanism.

Method

HCT116 cells cultured in vitro were divided into the three groups: no-load infection group, cells were not treated; control lentivirus group, empty vector control lentivirus (LV-GFP) infected HCT116 cells; MBP-1 overexpression lentivirus group (MBP-1 group) : Lentivirus overexpressing MBP-1 (LV-MBP-1-GFP) infected HCT116 cells. The expression of MBP-1 mRNA in each group was detected by RT-PCR, the proliferation rate of cells was observedby CCK-8 test, cell cycle was determined by flow cytometry, and the expression of MBP-1, NF-κB p65, c-Myc, Cyclin D1, Bcl-2, Bax and cleaved caspase-3 proteins was measured by Western blot. SPSS 22.0 was applied to conduct statistical analysis. The data collected from the three groups were analyzed by one-way ANOVA, while F-test was conducted to determinethe homogeneity of variance. If the variances were shown to be homogeneous, LSD test would be carried out for comparisonto be performed between different groups, otherwise Dunnett test would be conducted for comparison to be drawn between different groups.

Results

Compared with control lentivirus group, the expression of MBP-1 mRNA and protein was significantly increased in MBP-1 group (MBP-1 mRNA:1.02±0.15 vs 4.56±1.03; MBP-1 protein: 0.18±0.01 vs 0.72±0.10; P< 0.001) . Relative to the control lentivirus group [S phase (39.12±2.18) ﹪, G2/M phase (14.81±1.02) ﹪], the MBP-1 group was observed to be in the S phase (45.64±3.21) ﹪ and the G2/M phase (23.16±2.12) ﹪, where a significantly increase of percentage was discovered (P< 0.001) . The expression level of Bcl-2 protein showed declining trend (0.23±0.02, P< 0.001) . In comparison with the control lentivirus group [ (0.55±0.10) , (0.45±0.08) ], the levels of Bax (0.76±0.11) and cleaved caspase-3 protein expression (0.81±0.11) were improved in MBP-1 group (P< 0.001) . Nevertheless, the proliferation of cells (OD value) at 48 h (0.43±0.03) and 72 h (0.52±0.09) , as well as the percentage (31.36±2.02) ﹪ of cells at the G0/G1 phase in the MBP-1 group were reduced when compared to the control lentivirus group [ (46.06±1.89) ﹪, (0.61±0.13) , (0.79±0.15) , (0.62±0.09) ] (P< 0.001) , as were the levels of NF-κB p65 (0.16±0.03) (P< 0.001) , c-Myc (0.43±0.05) (P< 0.001) and CyclinD1 protein expression (0.32±0.001) (P< 0.001) . There was no significant difference observed in the indicators between the control group and the NC group.

Conclusion

Overexpression of MBP-1 can be effective in suppressing the proliferation of HCT116 cells and inducing cell cycle arrest in S phase. Moreover, its mechanism is speculated to be associated with the inhibited activation of NF-κB signaling pathway.

表1 引物序列表
图1 Western blot检测结肠癌细胞中MBP-1蛋白表达
表2 三组细胞中MBP-1 mRNA和蛋白相对表达量比较(±sn = 3)
表3 两组结肠癌HCT-116细胞的OD值比较(±sn = 3)
表4 MBP-1过表达对结肠癌HCT-116细胞周期的影响(±sn = 3)
图2 MBP-1过表达对结肠癌HCT-116细胞凋亡蛋白表达的影响
表5 MBP-1过表达对结肠癌HCT-116细胞凋亡蛋白表达的影响(±sn = 3)
图3 Western blot检测NF-κB p65、c-Myc和CyclinD1蛋白的表达
表6 MBP-1过表达对NF-κB信号通路相关蛋白表达的影响(±sn = 3)
1
郭天安, 谢丽, 赵江, 等. 中国结直肠癌1988-2009年发病率和死亡率趋势分析[J]. 中华胃肠外科杂志, 2018, 21(1):33-40.
2
Shimokawa M, Ohta Y, Nishikori S, et al. Visualization and targeting of LGR5+ human colon cancer stem cells[J]. Nature, 2017, 545(7653): 187-192.
3
Sanchez-Lopez E, Flashner-Abramson E, Shalapour S, et al. Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signaling[J]. Oncogene, 2016, 35(20):2634-2644.
4
Khan SA, Zeng Z, Shia J, et al. EGFR gene amplification and KRAS mutation predict response to combination targeted therapy in metastatic colorectal cancer[J]. Pathol Oncol Res, 2017, 23(3):673-677.
5
Zhong X, Lee HN, Surh YJ. RvD1 inhibits TNFα-induced c-Myc expression in normal intestinal epithelial cells and destabilizes hyper-expressed c-Myc in colon cancer cells[J]. Biochem Biophys Res Commun, 2018, 496(2):316-323.
6
He X, Tan X, Wang X, et al. C-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion[J]. Tumour Biol, 2014, 35(12):12181-12188.
7
Sengupta P, Banerjee N, Roychowdhury T, et al. Site-specific amino acid substitution in dodecameric peptides determines the stability and unfolding of c-MYC quadruplex promoting apoptosis in cancer cells[J]. Nucleic Acids Res, 2018, 46(19):9932-9950.
8
Ciribilli Y, Singh P, Spanel R, et al. Decoding c-Myc networks of cell cycle and apoptosis regulated genes in a transgenic mouse model of papillary lung adenocarcinomas[J]. Oncotarget, 2015, 6(31):31569-31592.
9
郭三君, 谢勇恩. c-Myc启动子结合蛋白1与肿瘤[J]. 川北医学院学报, 2016, 31(5):773-776.
10
欧阳灿晖, 谢军, 李君玉, 等. MBP-1及COX-2与结肠癌关系的初步研究[J]. 中国保健营养, 2016, 26(14):108-109.
11
施鑫鹤, 耿晢, 施星臣, 等.RNA干扰下调MBP-1对骨肉瘤Saos-2细胞生物学的影响[J]. 中国医科大学学报, 2016, 45(7):604-609.
12
Plewka D, Plewka A, Miskiewicz A, et al. Nuclear factor-kappa B as potential therapeutic target in human colon cancer[J]. J Cancer Res Ther, 2018, 14(3):516-520.
13
Lu YX, Ju HQ, Wang F, et al. Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis[J]. Cancer Lett, 2016, 380(1):87-97.
14
Li H, Fang Y, Niu C, et al. Inhibition of cIAP1 as a strategy for targeting c-MYC-driven oncogenic activity[J]. Proc Natl Acad Sci U S A, 2018, 115(40):E9317-E9324.
15
侯丛丛, 马晓骊, 陈虹, 等. YAF2靶向cyclin D1表达促进肿瘤细胞增殖[J]. 基础医学与临床, 2018, 38(6):764-770.
16
陈家骅, 李元明, 王磊, 等. MBP-1在人食管癌细胞株Ec109细胞增殖,凋亡和侵袭中的作用[J]. 重庆医学, 2018, 47(10):1318-1321.
17
Hsu KW, Wang AM, Ping YH, et al. Downregulation of tumor suppressor MBP-1 by microRNA-363 in gastric carcinogenesis[J]. Carcinogenesis, 2014, 35(1):208-217.
18
Ghosh AK, Steele R, Ray RB. C-myc promoter-binding protein 1 (MBP-1) regulates prostate cancer cell growth by inhibiting MAPK pathway[J]. J Biol Chem, 2005, 280(14):14325-14330.
[1] 孔莹莹, 谢璐涛, 卢晓驰, 徐杰丰, 周光居, 张茂. 丁酸钠对猪心脏骤停复苏后心脑损伤的保护作用及机制研究[J]. 中华危重症医学杂志(电子版), 2023, 16(05): 355-362.
[2] 张晓燕, 肖东琼, 高沪, 陈琳, 唐发娟, 李熙鸿. 转录因子12过表达对脓毒症相关性脑病大鼠大脑皮质的保护作用及其机制[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 540-549.
[3] 刘星辰, 刘娟, 魏宝宝, 刘洁, 刘辉. XIAP与XAF1异常表达与卵巢癌的相关性分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 419-427.
[4] 姚宏伟, 魏鹏宇, 高加勒, 张忠涛. 不断提高腹腔镜右半结肠癌D3根治术的规范化[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 1-4.
[5] 杜晓辉, 崔建新. 腹腔镜右半结肠癌D3根治术淋巴结清扫范围与策略[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 5-8.
[6] 江振剑, 蒋明, 黄大莉. TK1、Ki67蛋白在分化型甲状腺癌组织中的表达及预后价值研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 623-626.
[7] 刘硕儒, 王功炜, 张斌, 李书豪, 胡成. 新型溶瘤病毒M1激活内质网应激致前列腺癌细胞凋亡的机制[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 388-393.
[8] 于迪, 于海波, 吴焕成, 李玉明, 苏彬, 陈馨. 发状分裂相关增强子1差异表达对胆固醇刺激下血管内皮细胞的影响[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(05): 264-270.
[9] 韩晓娟, 徐佳倩, 朱玉兰, 王莹, 李源, 冯珺, 邵东. HHLA2过表达胃癌细胞株构建及细胞功能的初步研究[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 373-377.
[10] 李英茹, 李非, 张玉茹, 刘莉婷. 单点-点压法注射纳米碳在腹腔结肠癌根治术中应用探讨[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 414-417.
[11] 邓世栋, 刘凌志, 郭大勇, 王超, 黄忠欣, 张晖辉. 沉默SNHG1基因对膀胱癌细胞增殖、凋亡、迁移和铁死亡的影响[J]. 中华临床医师杂志(电子版), 2023, 17(07): 804-811.
[12] 张敏洁, 张小杉, 段莎莎, 施依璐, 赵捷, 白天昊, 王雅晳. 氢气治疗心肌缺血再灌注损伤的作用机制及展望[J]. 中华临床医师杂志(电子版), 2023, 17(06): 744-748.
[13] 朴成林, 蓝炘, 司振铎, 冯健, 安峰铎, 李强, 谈明坤, 赵娜, 冷建军. 局部晚期右半结肠癌行结肠癌根治联合胰十二指肠切除术疗效分析:附5例报告[J]. 中华临床医师杂志(电子版), 2023, 17(06): 666-670.
[14] 郭如烨, 孟黎明, 陈楠, 宋玉莹, 尹海燕, 郭岩. Apelin/APJ系统对帕金森病模型的神经保护作用及机制研究进展[J]. 中华诊断学电子杂志, 2023, 11(04): 276-282.
[15] 邱甜, 杨苗娟, 胡波, 郭毅, 何奕涛. 亚低温治疗脑梗死机制的研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 518-521.
阅读次数
全文


摘要